Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4901 in Females With Polycystic Ovary Syndrome
NCT01872078Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pavinetant in polycystic ovary syndrome (PCOS), sponsored by AstraZeneca. Started Jun 2013; status: completed.
02
Drugs
pavinetant
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT01872078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01872078.